Experts recognize the strategy of the new company CEO John Chen. The firm has raised the price target of the company up to $ 10 per share, implying an upside of over 10%.
Blackberry since January 1 .jpg)
Barclays has raised to overweight recommendation on Microsoft from neutral. Have also increased the price target to $ 42 per share, representing an increase of over 15% compared to Thursday’s close.
Janney Capital Markets has led to buy its recommendation on shares of Abercrombie .
Analysts at Goldman Sachs have also been fixed in the retail sector and have raised its bid for the shares of Macy’s to buy from neutral.
Cowens & Co have downgraded its rating on the Pfizer pharmaceutical to like the market since the previous overweight.
Several firms have focused on analyzing the evolution of Micron Technology after the publication of their accounts. Thus, analysts at Argus initiated coverage with a Buy rating and a target price of $ 31 per share.
Sterne Agee has reiterated its commitment to buy with a price target slightly lower than that of their colleagues, $ 28.Sterne Agee downgraded the recommendation Applied Micro Circuits to neutral. They have also lowered the price target to $ 14 per share.
Goldman Sachs has improved recommendation Target Corp from neutral to buy with a price target of $ 72 per share. At the same time the company has lowered its profit forecast. Argus has raised the recommendation Alliant Techsystems from hold to buy with a price target of $ 139 per share compared to $ 125.25 at the close of the last day.Bank of America Merrill Lynch has downgraded the recommendation Barracuda Networks to neutral from prior buy after the recent publication of their accounts.
Credit Suisse has initiated Emerald Oil coverage with overweight recommendation and a target price of $ 10 per share.
Piper Jaffray has worsened its recommendation Sequenom to neutral . since overweight
Goldman Sachs has downgraded its bet on WisdomTree Investments to neutral from buy
No comments:
Post a Comment